Comparison of Analgesic Efficacy and Occurrence of Emesis Among Different Background Infusion and Bolus Administration Regimens of Fentanyl Based Intravenous Patient-controlled Analgesia in Patients After Laparoscopic Assisted Gastrectomy - a Randomized Blind Study -
NCT ID: NCT01863355
Last Updated: 2013-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
225 participants
INTERVENTIONAL
2013-05-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Differences in Incidence of Common Side Effects Between Young Adults and Elderly Patients While Using IV-PCA
NCT02448862
Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function
NCT04295109
Comparison of the Effects of Continuous Epidural Analgesia and Continuous Intravenous Analgesia on Postoperative Bowel Movement in Patients Undergoing Laparoscopic Gastrectomy
NCT02458573
Dual-chamber Patient-controlled Analgesia for Postoperative Recovery
NCT07051109
Effect of Intravenous Patient-controlled Analgesia (IV-PCA) With Fentanyl in Adults for Acute Postoperative Pain Control
NCT01527890
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
B0
(basal rate 0cc/hr, bolus 3cc, lockout time 10min)
B0 group: bolus 0.6mcg/kg without background infusion
BL
(basal rate 1cc/hr, bolus 2cc, lockout time 10min)
BL group: bolus 0.4mcg/kg with background infusion rate 0.2mcg/kg/hr
BH
(basal rate 2cc/hr, bolus 1cc, lockout time 10min)
BH group: bolus 0.2mcg/kg with background infusion rate 0.4mcg/kg/hr
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
B0 group: bolus 0.6mcg/kg without background infusion
BL group: bolus 0.4mcg/kg with background infusion rate 0.2mcg/kg/hr
BH group: bolus 0.2mcg/kg with background infusion rate 0.4mcg/kg/hr
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA class I and II
* Gastric cancer patients who are scheduled to receive laparoscopic gastrectomy
Exclusion Criteria
* Renal failure
* Liver failure
* Chronic drug or alcohol abuser
* Anti-cancer chemotherapy
* Chronic opioid use
* Use of antiemetics within 24hrs for nausea and vomiting
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Severance Hospital, Yonsei University Health System
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4-2013-0176
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.